StockData
LITSNasdaqPharmaceutical PreparationsFiscal year ends June 30

Lite Strategy, Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.16+0.01 (+0.87%)

Close on Oct 19, 2026

Market cap
$40.13M
P/E (TTM)
–
Dividend yield
–

Share price

−$0.72 (−38.30%)past year

Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$40.13M
P/E ratio
–
Price to sales
–
Price to book
0.96
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
-$71.15M
EPS, diluted
-$2.06
Book value per share
$1.20
Diluted shares
35M

Fifteen years at a glance

Fiscal years 2012 to 2026, USD

Revenue

–

Gross profit

–

Operating income

-$66.58M

Net income

-$71.15M

EPS, diluted

-$2.06

Free cash flow

–
Reported period